With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than ...
a common and debilitating complication of Parkinson’s disease treatment. The research explored how this condition affects the brain’s motor cortex and evaluated ketamine, an anesthetic ...
Repetitive transcranial magnetic stimulation (rTMS) of the brain is a noninvasive, well-tolerated technique that can modify cerebral cortex ... rTMS for motor function in Parkinson disease ...
Deep-brain stimulation may effectively treat slow movement, tremor, and rigidity in Parkinson’s patients by reducing synchronicity of neural activity in the motor cortex. Jef Akst was managing editor ...
Recently, the researchers identified two distinct subpopulations of mitral/tufted (M/T) cells within the OB that project to the anterior piriform cortex (aPC) and entorhinal cortex (EC). These neural ...
GlobalData on MSN3mon
AbbVie’s Phase III trial of Parkinson’s disease treatment meets primary endpointUS-based pharmaceutical company AbbVie has reported that the Phase III TEMPO-2 trial of tavapadon, its D1/D5 partial agonist ...
New research suggests that dancing might lighten the depression suffered by many people with Parkinson’s disease, an approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback